MedTrace Logo

Transcranial Direct Current Stimulation Therapy for Bipolar Depression

NCT05436613 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 44

Last updated 2025-08-14

Study results available
· View outcomes & findings →

Summary

Bipolar disorder is a severe and disabling disorder. The course of illness is often progressive but is highly heterogeneous between individuals and within the lifetime for an individual. The most common treatments are medications. However, for many individuals, combinations of medications are often required, and full recovery is infrequent.

The novel brain stimulation treatment, transcranial direct current stimulation (tDCS), is a potential first-line treatment for bipolar depression. The present research question is whether tDCS can be provided as a home-based treatment for bipolar depression for adults with bipolar disorder.

Conditions

Interventions

DEVICE

Transcranial Direct Current Stimulation

tDCS at 2mA in 30 minute sessions for 5 sessions per week for 3 weeks and then 2 sessions per week for 3 weeks.

Sponsors & Collaborators

  • University College, London

    collaborator OTHER

  • King's College London

    collaborator OTHER

  • Technische Universität Dresden

    collaborator OTHER

  • University of East London

    lead OTHER

Principal Investigators

  • Cynthia Fu, MD, PhD · University of East London

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-05-01
Primary Completion
2024-05-30
Completion
2024-05-30

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05436613 on ClinicalTrials.gov